Press Releases
BillionToOne to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Read
News & Media
Press Releases
BillionToOne Announces Global Collaboration to Provide its UNITY Fetal Antigen™ Clinical Trial Assay in Johnson & Johnson Phase 3 Clinical Trial of Nipocalimab in Hemolytic Disease of the Fetus and Newborn
Read
Media Coverage
UNITY Fetal Risk Screen has earned a spot in AJHG’s Genomic Medicine Year in Review: 2023, recognized as a top 10 key advancement in applying genomics to clinical care.
Read
Media Coverage
BillionToOne recognized as one of the most promising digital health companies of 2023 by CB Insights
Read
Press Releases
BillionToOne Announces Clinical Outcomes Data for UNITY Fetal Risk™ Screen, Demonstrating Exceptional Accuracy in General Pregnancy Population
Read
Press Releases
BillionToOne Publishes UNITY Fetal RhD and Fetal Antigen NIPT Clinical Validity Demonstrating >99.9% Accuracy
Read
